These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10297673)

  • 1. Medicaid drug programs.
    McGovern J
    Nurs Homes; 1980; 29(1):30-1. PubMed ID: 10297673
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 3. A governmental contribution to rising drug expenditures in skilled nursing facilities.
    Boisseree VR
    J Long Term Care Adm; 1980; 8(2):21-34. PubMed ID: 10298043
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced prescription size: a question of health care or money? The answer is money, say drug plans.
    Tidball P
    Can Pharm J; 1980 May; 113(5):165-6. PubMed ID: 10249549
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 6. Do drug copayments work?
    David J
    CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copayment for pharmaceutical services in a Medicaid program.
    Nelson AA; Quick MR
    Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
    Yesalis CE; Lipson DP; Norwood GJ; Helling DK; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):737-45. PubMed ID: 6381921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior-authorization programs for controlling drug spending.
    Hamel MB; Epstein AM
    N Engl J Med; 2004 Nov; 351(21):2156-8. PubMed ID: 15548775
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
    Gitlin M; Wilson L
    Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.
    Nelson AA; Reeder CE; Dickson WM
    Med Care; 1984 Aug; 22(8):724-36. PubMed ID: 6433121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: government perspective.
    Parks JJ
    J Clin Psychiatry; 2003; 64 Suppl 17():37-8. PubMed ID: 14680428
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost of pharmaceutical benefits.
    Mackereth MB
    N Z Med J; 1988 Jul; 101(849):460-1. PubMed ID: 3399187
    [No Abstract]   [Full Text] [Related]  

  • 19. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
    Lamers LM; van Vliet RC
    Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing use of new prescription drugs: a case study.
    Foote SM; Etheredge L
    Health Aff (Millwood); 2000; 19(4):165-70. PubMed ID: 10916970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.